SOURCE: Gentiae Clinical Research

June 13, 2006 07:00 ET

Gentiae Announces Additions to Senior Management Team

Industry Veterans Join Leading Clinical ECG and Imaging Core Lab

SAN BRUNO, CA -- (MARKET WIRE) -- June 13, 2006 -- Gentiae Clinical Research, Inc., the leader in comprehensive cardiac safety assessment services, announced today the addition of two new executives to their senior management team. Peter G. Amatulli was appointed vice president of commercial development, responsible for managing business partnerships, as well as building and leading all global sales efforts. In addition, C. Anthony Jones, M.D., was appointed vice president of marketing, with responsibility for development and primary execution of Gentiae's market strategy as well as developing key strategic partnerships and alliances.

"Gentiae has built a reputation for delivering the highest quality cardiac safety data in the industry," said Craig Albright, President and CEO of Gentiae, "and the addition of senior leadership in the sales and marketing functions ensures our ability to build on a strong foundation and extend that expertise globally. Pete and Tony's efforts will not only increase our competitiveness in the market, but will also allow us to raise the bar with respect to the breadth and quality of services that we deliver to our customers."

Mr. Amatulli has broad experience in the clinical research industry. Before joining Gentiae, Amatulli served as vice president of sales and marketing at MDS Pharma Services. Additional experience includes his role as senior vice president of global new business development at Kendle International, and vice president of sales and clinical support services for Covance Inc.

Dr. Jones brings nearly a dozen years of experience in developing and marketing innovative businesses in the healthcare market. First with Deloitte Consulting, then as vice president of the Health and Wellness unit at Scient, he has led marketing strategy projects for some of the industry's leading companies. Previously, Dr. Jones was a Director at Reuters Health where he managed the creation of "," a leading healthcare news licensing business.

About Gentiae

Gentiae Clinical Research, Inc., based in the San Francisco Bay Area, is the leader in comprehensive cardiac safety assessment for clinical trials including electrocardiography (ECG), Holter, echocardiography (ECHO) and angiography. As a spin-off from the non-profit Ischemia Research and Education Foundation, Gentiae inherits nearly 20 years of experience interpreting cardiac safety data for global studies. Leveraging its industry-leading quality data, Gentiae is able to deliver tangible value to clients through efficient, cost-effective cardiac safety and functional studies in all phases of development. Gentiae also provides supporting clinical services that include protocol design, project management, data management, statistical analysis, report writing, and regulatory support.

The name Gentiae [jen ·tee · ay'], based on a Latin root, means "people of the world." More information about Gentiae can be found at

Contact Information